HSBC/CALL/FRESENIUS MEDICAL CARE/55/0.1/18.12.24 Share Price

Warrant

DE000TT5ZDT5

Market Closed - BOERSE MUENCHEN 01:07:30 29/06/2024 am IST
0.023 EUR 0.00% Intraday chart for HSBC/CALL/FRESENIUS MEDICAL CARE/55/0.1/18.12.24
Current month-50.00%
1 month-50.00%
Date Price Change
28/24/28 0.023 0.00%
27/24/27 0.023 0.00%
26/24/26 0.023 0.00%
25/24/25 0.023 -11.54%
24/24/24 0.026 -10.34%

Real-time BOERSE MUENCHEN

Last update June 29, 2024 at 01:07 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer HSBC
WKN TT5ZDT
ISINDE000TT5ZDT5
Date issued 09/03/2021
Strike 55
Maturity 18/12/2024 (172 Days)
Parity 10 : 1
Emission price 1.12
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 2.07
Lowest since issue 0.023
Spread 0.016
Spread %61.54%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.76 EUR
Average target price
39.97 EUR
Spread / Average Target
+11.78%
Consensus